NIH Funding · FY2024
Total Funding
$3.6M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#1,975
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $3.6M across 2 grants · National rank #1975.
Top grants by award amount
Mark K Greenwald's NIH grant portfolio, ranked by award amount.
- 5UG3DA059285-02UG3Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)$3.3Maward amount
- 1T32DA060139-01T32TRAIN@wayne: Translational Research in Addiction and Integrative Neuroscience$239Kaward amount
Affiliations
Institutions that have administered grants for Mark K Greenwald.
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardPark Therapeutics, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1975
- 2024Entered Top 25% NationallyRanked #1975
- 2024Entered Top 10% NationallyRanked #1975
- 2024Multi-Institutional ResearchAwards at 2 institutions
Related investigators
Other NIH-funded PIs frequently associated with Mark K Greenwald.
Explore further
Find collaborators for Mark K Greenwald
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Park Therapeutics, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →